Catalyst Wire Dossier Catalyst Wire Dossier

Compound Kushen Injection

Kushen (Sophora flavescens) extract injection containing matrine/oxymatrine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Compound Kushen Injection, covering 2022-03-24 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer [Phase 4]

See pricing